Gaudium IVF and Women Health Limited, a company engaged in the IVF treatment in India, is planning to raise ₹165 crore through an Initial Public Offering.
[Fresh Issue ₹90 Cr + OFS ₹75 Cr]
Gaudium ivf ipo price is ₹75 – ₹79 per share
Gaudium IVF: History
The company was originally incorporated as Gaudium IVF and Women Health Private Limited, as a private limited company under the provisions of the Companies Act, 2013, on March 24, 2015.
The Company was then converted into a public limited company under a special resolution passed by the shareholders on September 28, 2024. Its name was subsequently changed to Gaudium IVF and Women Health Limited under a fresh certificate of incorporation issued by the Registrars of Companies on October 24, 2024.
Gaudium IVF: Business
Incorporated in 2015, Gaudium IVF and Women Health Ltd. is engaged in IVF (In Vitro Fertilization) treatment across India and has extended into several states in the country using a hub-and-spoke model.
The Company offers a vast range of specialized fertility and reproductive health services. Its advanced treatments include –
- In Vitro Fertilization (IVF),
- Intracytoplasmic Sperm Injection (ICSI),
- Intrauterine Insemination (IUI), and
- Ovulation Induction (OI).
All the treatments offered by the company are meticulously designed to address a variety of infertility challenges for both females and males.
It also offers a complete range of gynecological care treatment, including Polycystic Ovarian Disease (PCOD)/ Polycystic Ovary Syndrome (PCOS) and endometriosis.
The Company also provides a vast range of male infertility treatments, including advanced sperm retrieval techniques.
It also offers cryopreservation services for egg freezing for future fertilization, utilizing state-of-the-art technology to ensure optimal success rates in future IVF cycles.
Gaudium IVF also offers hysteroscopic and laparoscopic surgeries for the diagnosis and treatment of infertility-related issues, as well as genetic testing options, including Preimplantation Genetic Testing (PGT).
PAN-India Presence
The company operates with more than 30 locations in India, which comprises,
- 7 hubs (IVF centers), and
- 28 spokes (the company has entered into a strategic alliance with Spokes Infertility Expert for spreading awareness about IVR and Assisted Reproductive Technology (ART) treatment).
Overseas Patients
The company also serves patients from foreign countries, including Canada, Kenya, Oman, the United Kingdom, the United States, and South Africa.
LAST ARTICLE – Tenneco Clean Air news
Strategies Ahead
- Establishment of New IVF Centers
- Launching of FMCG Products through EKK Global (a Wholly Owned Subsidiary of the company)
Company Promoters
- Dr. Manika Khanna,
- Dr. Peeyush Khanna,
- Vishad Khanna.
Refer to Gaudium IVF DRHP for detailed information.
IPO Details
Gaudium ivf ipo date: 20 Feb – 24 Feb 2026
Minimum Amount: ₹14,931
Minimum Bid: 189 Shares
Face Value: ₹5
Listing On: NSE, BSE
Financial
Book Running Lead Manager
Sarthi Capital Advisors
CONCLUSION
FinBlab recommends ‘SUBSCRIBE‘ ratings on Gaudium IVF IPO.
Do come back to know more about “upcoming ipos“
Disclaimer: The contents and data presented here are just for your information & personal use only. While much effort is made to provide the information, I (Vishal Dalwadi) or “FinBlab” do not guarantee the accuracy, correctness, completeness or reliability of any information or data displayed herein and shall not be held responsible.